November 19th, 2026First patient dosed in EMERALD trial of EO2002 for corneal edemaThe phase 2 EMERALD trial compares 2 doses of EO2002 with placebo, with a 15-letter BCVA gain at 26 weeks as the primary end point.Read more
October 24th, 2026Takeaways from this week in optometry: October 16-23This week's top stories include breaking FDA approvals, insights on AI-assisted front desk management, and more. Read more
November 19th, 2026High Point University optometry school earns ACOE preliminary approvalThe school will be admitting its inaugural Doctor of Optometry class in summer 2027, with full accreditation possible in 2030-31.Read more
November 18th, 2026Alice Epitropoulos, MD, on phentolamine for presbyopia treatmentThe FDA approved the Supplemental New Drug Application for phentolamine 0.75% (Ryzumvi, Opus Genetics/Viatris) to treat presbyopia.Read more
November 12th, 2026Scope Health launches Optase Heat Mask Pro for MGD and dry eyeThe reusable moist heat mask gives ODs another at-home option for patients seeking dry eye and MGD symptom relief.Read more
November 7th, 2026Takeaways from this week in optometry: November 2-6A wet AMD biosimilar approval leads this week’s recap, plus Medicare pay updates and tips to avoid burnout and losing patients.Read more
November 2nd, 2026FDA approves ranibizumab biosimilar Lucamzi for wet AMDThe approval followed complete response letters tied to inspection and manufacturing issues.Read more
November 2nd, 2026More magic in Anaheim: Highlights from AAOpt 2026What to take away on PBM, hormonal eye health, and GLP-1 receptor agonists from this year’s meeting.Read more